We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03799744
Recruitment Status : Active, not recruiting
First Posted : January 10, 2019
Last Update Posted : March 28, 2022
Sponsor:
Collaborators:
VCN Biosciences, S.L.
BioClever 2005 S.L.
AstraZeneca
Information provided by (Responsible Party):
Institut Català d'Oncologia

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 31, 2023
Estimated Study Completion Date : January 31, 2023